Artemis Hospitals
| India | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $28,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $20,500 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $15,000 | da $36,000 | da $140,000 |
| Trapianto autologo di midollo osseo | da $11,000 | da $31,500 | da $50,000 |
| Radioterapia per il cancro colorettale | da $3,200 | da $7,000 | da $12,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Linfoma di Burkitt. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Linfoma di Burkitt e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Linfoma di Burkitt.
Il medico è un ematologo-oncologo pediatrico con specializzazione nel trapianto di midollo osseo. Ha una vasta esperienza nel trattamento di disturbi del sangue complessi e tumori nei bambini. Il suo focus clinico include la gestione della leucemia pediatrica, del linfoma e di altre malignità ematologiche. Il medico è riconosciuto per la sua esperienza nell'esecuzione di trapianti di midollo osseo e ha contribuito ai progressi nell'oncologia pediatrica attraverso la ricerca clinica e l'innovazione.<\/p>
Il medico è un ematologo-oncologo altamente esperto presso l'HCG Manavata Cancer Centre, Nashik, con oltre 13 anni di esperienza in leucemia, mieloma multiplo e trapianto di midollo osseo. <\/p>
Laureato con un MBBS presso il Grant Medical College e Sir JJ Hospital, il medico ha ulteriormente perseguito un MD in Patologia presso il Lokmanya Tilak Municipal Medical College, Sion, e Mumbai. <\/p>
Inoltre, il medico possiede un DM in Ematologia Clinica dal Medical College, Calcutta, e ha ricevuto premi per professionalità e duro lavoro, sottolineando la sua reputazione come specialista competente e qualificato.<\/p>
Il medico possiede un MD in Oncologia Radioterapica e lavora come consulente. Specializzandosi in tecniche avanzate di trattamento del cancro, il medico offre servizi tra cui Tomoterapia-H, Acceleratore Lineare e Brachiterapia. Queste modalità sono utilizzate per fornire una terapia radiante precisa, minimizzando i danni ai tessuti sani circostanti e migliorando l'efficacia del trattamento.<\/p>
Standard treatment in India involves intensive short-duration multi-agent chemo-immunotherapy combined with mandatory central nervous system prophylaxis. Indian hospitals primarily utilize R-CODOX-M/R-IVAC or DA-EPOCH-R regimens. These protocols incorporate Rituximab and intrathecal chemotherapy to manage this aggressive malignancy while preventing disease spread.
Bookimed Expert Insight: Data from top-tier Indian networks like Manipal and Apollo indicates a shift toward DA-EPOCH-R to minimize treatment abandonment. While R-CODOX-M is powerful, its requirement for advanced inpatient monitoring and prolonged stays can be challenging. Facilities like HCG Manavata and Dr. Rela Institute utilize precision technologies like linear accelerators with 1 mm accuracy for targeted cases, ensuring high-density treatment even in resource-limited settings.
Patient Consensus: Patients emphasize that treatment must start immediately after diagnosis as surgery alone is ineffective. They often note that the first chemotherapy cycle is the most critical period, requiring strict medical monitoring for rapid tumor breakdown.
Indian medical centers report a 3-year survival rate between 66% and 70% for Burkitt lymphoma. Specialized adult cohorts completing intensive therapy achieve a 73% 2-year survival rate. Pediatric success remains high at 70% when patients receive immediate treatment at hematology-oncology facilities.
Bookimed Expert Insight: Success in India often depends on high-volume centers with dedicated hematology units. Manipal Hospitals and Apollo Hospital Indraprastha each serve over 1,000,000 patients annually. Large networks like these maintain specialized oncology beds and critical care support. This infrastructure is essential for managing the intensive treatment required for Burkitt lymphoma.
Patient Consensus: Patients emphasize that speed is vital because this cancer progresses rapidly. Many note that while chemotherapy is physically demanding, tumor shrinkage often begins shortly after the first cycle.
Doctors emphasize central nervous system prophylaxis to prevent cancer cells from hiding in sanctuary sites. The blood-brain barrier blocks standard intravenous chemotherapy from reaching these areas. Preventative treatment targets microscopic disease in the brain and spinal fluid to avoid high-risk relapse.
Bookimed Expert Insight: Indian oncology centers often combine specialized radiation technologies with intensive chemotherapy protocols. Dr. Prakash Pandit at HCG Manavata Cancer Centre utilizes Tomotherapy-H for targeted tumor irradiation. This specialized equipment allows for precise dosing near critical nervous system structures. Choosing a clinic with both hematology-oncology and advanced radiation departments ensures seamless delivery of complex prophylaxis protocols.
Patient Consensus: Patients note that nervous system treatment is often more intense than expected. Many wish they had known about the regular lumbar punctures required to keep the spinal fluid clear.
Early diagnosis and immediate start of intensive chemotherapy are the most critical factors for long-term Burkitt lymphoma survival. This aggressive cancer doubles in size every 24 hours. Vital survival pillars include sentinel lymph node biopsy, PET-CT staging, and immediate access to hematology-oncology specialist care.
Bookimed Expert Insight: India’s top oncology centers like Apollo and Manipal manage over 1,000,000 patients annually. This massive volume ensures hematologists are prepared for rare, aggressive cancers. We notice that JCI-accredited clinics in Bengaluru and Delhi often offer IBM Watson for precision mapping. This helps doctors select the most effective regimens for rapid-growth tumors faster.
Patient Consensus: Patients emphasize that getting a fast biopsy and starting treatment immediately is life-saving. They note it is vital to find a team ready to handle intense side effects right away.
Surgery is not the primary treatment for Burkitt lymphoma because these tumors respond exceptionally well to chemotherapy. High-volume Indian centers prioritize systemic therapy over surgical resection. Doctors utilize surgery mainly for diagnostic biopsies or emergency complications like bowel obstructions, perforations, or intussusception requiring urgent repair.
Bookimed Expert Insight: Indian oncology centers like Artemis and Manipal focus on high-speed diagnostics rather than surgical removal to improve outcomes. Data shows top-tier facilities emphasize starting intensive chemotherapy immediately after biopsy. Centers like Global Hospital Chennai and Apollo Indraprastha handle over 1,000,000 patients annually. This massive volume ensures pathology teams can confirm Burkitt lymphoma quickly. This allows patients to bypass major surgical trauma and move straight to life-saving systemic treatments.
Patient Consensus: Patients note that surgery is almost always just a step for diagnosis or emergencies rather than the cure. They emphasize finding a center that can start chemotherapy quickly once the biopsy results are ready.